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Background: Exact drug dosing in isolated limb perfusion (ILP) and infusion (ILI) is essential. We developed and
evaluated a model for calculating the volume of extremities and compared this model with body weight- and
height-dependent parameters.
Methods: The extremity was modeled by a row of coupled truncated cones. The sizes of the truncated cone bases
were derived from the circumference measurements of the extremity at predefined levels (5 cm). The resulting
volumes were added. This extremity volume model was correlated to the computed tomography (CT) volume data of
the extremity (total limb volume). The extremity volume was also correlated with the patient’s body weight, body mass
index (BMI) and ideal body weight (IBW). The no-fat CT limb volume was correlated with the circumference-measured
limb volume corrected by the ideal-body-weight to actual-body-weight ratio (IBW corrected-limb-volume).
Results: The correlation between the CT volume and the volume measured by the circumference was high and
significant. There was no correlation between the limb volume and the bare body weight, BMI or IBW. The correlation
between the no-fat CT volume and IBW-corrected limb volume was high and significant.
Conclusions: An appropriate drug dosing in ILP can be achieved by combining the limb volume with the simple
circumference measurements and the IBW to body-weight ratio.
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In light of the increasing incidence of obesity, there is an
ongoing debate about the correct dosing of systemic
chemotherapy and alternative weight models for the cal-
culation of drug dosage [1,2]. For the treatment of locally
advanced soft tissue sarcoma and malignant melanoma in
the extremities, isolated limb perfusion with TNF-alpha
and melphalan has proven to be one of the most effective
treatment modalities with limb salvage rates of approxi-
mately 80% for soft tissue sarcoma [3-8] and local re-
sponse rates of 90% for malignant melanoma [9-11].
Similar to systemic chemotherapy, the correct drug
dosing is of great importance for isolated limb perfusion* Correspondence: lars.podleska@uk-essen.de
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reproduction in any medium, provided the orand isolated limb infusion, especially with TNF-alpha
and melphalan (TM-ILP), to ensure the ideal balance of
the maximum therapeutic effects with the lowest re-
gional toxicity [12-15].
The majority of authors recommend determining the
drug dosage according to the limb volume as first pro-
posed by Wieberdink et al. [16,17]. There are some alter-
native dosage models that have been developed, such as
dosage by body weight [18] and dosage by ideal body
weight [19-21].
Though many recent articles do not explicitly mention
the underlying drug dosage model, dosage according to
the limb volume seems to be the leading dosage model.
Measurements for the limb volume are acquired either
by the original water displacement method described by
Wieberdink or by circumference measurements, which
are still performed in many European ILP centers, includ-
ing our own [14,19].al Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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tomography (CT) scanning. CT scanning is most often
used in liver transplantation and offers fast and accur-
ate measurement of the organ volume [22-25]. Several
authors have also described the use of CT scanning for
volumetry in isolated limb perfusion (ILP)/isolated limb
infusion (ILI), but due to the high cost and the radi-
ation exposure, CT scanning for volumetry has not
gained wide acceptance, despite its high accuracy.
Due to the high incidence of compartment syndrome
at our institution between January 2011 and July 2011,
we started investigating all possible factors that could
influence compartment syndrome, including our drug
dosage model. Since we do know from Deroose and co-
authors that “dose matters” [12], we have not just
chosen dose reduction to lower the risk for compart-
ment syndrome because that would increase the risk for
a reduced response of the tumor to the treatment.
Since the drug dose for melphalan was predefined (10
to 11 mg per liters of leg volume and 13 mg per liter of
arm volume) [26,27] and only depended on the limb
volume, we started our investigation by taking a closer
look at the volume model used for calculating the abso-
lute drug dosage because we believe that the exact dos-
age of the drugs is essential for maintaining the balance
between a good response of the tumor and a low rate of
local complications.
Considering the increasing interest in ILP and ILI
and the number of newly developing ILP and ILI pro-
grams, we felt it was important to characterize the dif-
ferent drug dosage models and to develop a simple tool
for estimating the limb volume and drug dosage in iso-
lated limb perfusion.
The aim of this study was to validate a mathematical
volume model for estimating the limb volume with simple
circumference measurements and to compare the volume
model data to weight-based drug dosage data, such as the
actual body weight (ABW), body mass index (BMI) and
ideal body weight (IBW). An additional aim of this study
was to provide a web-based calculation tool that would
allow for on- and offline calculation of standardized limb
volumes [28].Figure 1 Calculation of limb volume by circumference measure.
Measures are taken every 5 cm, and the volume of a truncated cone is
calculated from two neighboring circumference measures. Volumes are
summed, representing the total calculated limb volume.Methods
We performed a retrospective analysis of our ILP data-
base and identified all patients who received an isolated
limb perfusion and a digitally archived whole body sta-
ging positron emission tomography/computed tomog-
raphy (PET/CT) that included the extremity before the ILP.
All patients scheduled for ILP received a pre-operative limb
volume estimation according to the circumference measure.
Those patients who had evaluable CT data and a completelydocumented limb volume estimation (by the circumference
measure) were included in this study.Calculation of limb volume by circumference measure
The limb volume for the estimation of drug dosage was
calculated by a standardized circumference measurement
one day before the scheduled ILP. All measurements were
performed while the patient was lying in a supine position.
The patients’ legs were kept straight, and the arms were
abducted to 90° at the shoulder. The extremity was marked
with a waterproof pen; beginning at the groin/axilla, a base
line was drawn (Figure 1), and markings were made at in-
tervals of 5 cm down to the ankle-/wrist-level. In cases
where the tumor affected the hand or foot, the distal ex-
tremity was included in the measurement. Beginning at the
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every 5 cm marking. All of the measured values were en-
tered into an Excel-table (Microsoft Excel 2003, Microsoft,
Redmond, WA, USA) or html/java-script-table [28].
The underlying calculation model was derived from
a row of the frustums of a cone (Figure 1) that closely
models the near circular volume of an extremity.
The volume (V) of the frustum of a cone is calculated
by V ¼ h⋅π3 ⋅ Circ12π






being 5 cm (the distance for each measure), Circ1 and
Circ2 being the two neighboring circumference mea-
sures. Each volume corresponds to that of a 5-cm seg-
ment of the extremity. The sum of all volumes equals
the total volume of the extremity.
A copy of the html/java-script table is available for on-
line use. The table can also be downloaded and stored
for offline use on any java-script-enabled browser [28].Estimation of limb volume by CT
The reference limb volume for each patient was de-
rived from CT data. Analysis was performed on the CT
workstation (Syngo, Siemens AG, Berlin, Germany). As
before, the proximal starting reference level was the
axilla/groin, and the measurement was carried down to
the wrist/ankle. As before, the distal extremity was in-
cluded in the measurement in cases in which the
tumor location was in the hand or foot. The extremity
volume was derived from automatic data segmentation
based on Hounsfield units (HU); the threshold was 200
HU, meaning that the surrounding air was not in-
cluded, and everything above the density of 200 HU
was included. The result was checked visually, and seg-
mentation errors were corrected manually.
Second, the “no-fat limb volume”, representing the
limb volume excluding the subcutaneous tissue, was
measured as described above with the threshold set
to -20 HU.Correlation between CT-calculated limb volume and
circumference-measured limb volume
All calculations were performed in SPSS 20 (IBM Cor-
poration, Armonk, NY, USA). The CT-calculated vol-
ume was correlated with the circumference-measured
limb volume. The Pearson’s product-moment correl-
ation coefficient (R) and its two-tailed significance were
calculated. A normal distribution was tested by the one-
sample Kolmogorov-Smirnov test.Correlation of limb volume with body weight, BMI
and IBW
The circumference-measured limb volume was corre-
lated with the patient’s ABW, BMI and IBW. The bodymass index was calculated according to the World
Health Organization (WHO) definition:
BMI ¼ Weight kgð Þ=Height mð Þ2:
The ideal body weight (IBW) was calculated by:
IBW kgð Þ ¼ 49:9þ 0:89
 Height mð Þ–152:4ð Þ for men and IBW kgð Þ
¼ 45:4þ 0:89
 Height mð Þ–152:4ð Þ for women:
Calculations were performed in separate groups for
the arms and legs. Again, the Pearson’s R and its two-
tailed significance were calculated.
Correlation between limb volume corrected by ideal body
weight and “no-fat CT volume”
To overcome the dilemma of the circumference-measured
limb volume matching the true limb volume while lacking
the possibility of fat reduction in obese patients, we
adapted a model presented by Beasley and coauthors in
2008 to fit our volume model [29]. With this adjustment,
we multiplied the measured limb volume with the quo-
tient of the ideal body weight and the actual body weight.
Vcorrected ¼ Vmeasured⋅ IBWABW
This calculation results in a new parameter, the IBW-
corrected limb volume, which represents the limb volume
minus any excess fat-tissue caused by obesity. This param-
eter was correlated with the “no-fat CT limb volume”
using the Pearson’s R and its two-tailed significance.
Results
Patient data
From our database, we identified 42 patients who received
an isolated limb perfusion and underwent a pre-operative
CT scan including the extremity. Of the 42 patients, 23
were male and 19 were female. The patients’ mean age
was 56.4 (20 to 81) years. Thirty-two patients received a
perfusion of the leg (12 iliac and 20 femoral) and 10 pa-
tients had perfusion of the arm (5 on the brachial level
and 5 on the axillary level). Thirty-three (79%) ILPs were
performed due to soft tissue sarcoma (STS), 5 due to mel-
anoma (12%) and 4 (10%) due to other tumors, including
high-grade chondrosarcoma, desmoid tumor, squamous
cell carcinoma of the bone and lymphoma.
Correlation between circumference measure and
CT measure
The mean volume estimated by CT was 10.8 (±3.673) li-
ters for legs and 3.21 (±0.932) liters for arms. In both
cases, the volume measured according to the circumfer-
ence was slightly lower at 10.3 (±3.219) liters for legs
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relation between the circumference-measured volume
and the CT-measured volume. Arms and legs had a
nearly perfect match with the regression line; therefore,
the mathematical correlation was performed for the
arms and legs in a single group. The Pearson’s R was ex-
tremely high and significant (r = 0.965; P <0.01).
Correlation of body weight, body mass index and ideal
body weight
For all diagrams (Figures 3, 4 and 5), arms and legs were
calculated separately. Figure 3 shows the correlation of the
ABW with the limb volume (by the circumference meas-
ure). For legs, the correlation was positive and highly sig-
nificant (r = 0.871; P <0.01); for arms, the correlation was
not statistically significant (r = 0.508).
The correlation of the BMI and limb volume reveals a
significant coherence for legs, as shown in Figure 4 (r =
0.781; P <0.01), while the correlation was not significant
for arms (r = 0.263).
Not surprisingly, we found that the ideal body weight
was the poorest predictor of the limb volume compared to
the actual body weight and body mass index (Figure 5). In
both cases (arm and legs), the correlation between the
ideal body weight and the limb volume was not significant
(r = 0.305 for legs; r = 0.466 for arms), which could be due
to the inability of the ideal body weight to account for the


















Figure 2 Correlation of limb volume measured by circumference mea
linear correlation between the two measures. Green dots represent arms a
represents a severely overweight patient who is still within the very narrowCorrection between limb volume and ideal body weight
To overcome the dilemma of the circumference-measured
limb volume matching the true limb volume while lacking
the possibility of fat reduction in obese patients, the
circumference-measured limb volume was corrected by
the quotient of the IBW per ABW. The mean leg volume
estimated by “no-fat CT” was 5.9 (±1.78) liters; the mean
leg volume by IBW-corrected limb volume was 8.1 (±1.56)
liters. Thus, the CT mean volume is 28% lower than the
clinical volume. For arms, the “no-fat CT volume” was 1.8
(±0.75) liters and the IBW-corrected limb volume was 2.4
(±0.69) liters; thus, there was a 23% lower volume for the
no-fat CT measure, which is expected because the “no-
fat” CT scan subtracts all subcutaneous fat-tissue (in
addition to the regular, non-obese fat).
As we can see in Figure 6, the correlation between
the “no-fat CT volume” and the IBW-corrected limb
volume is very high. The Pearson’s correlation coeffi-
cient was 0.833 and highly significant (P <0.01) for
both arms and legs together. As shown above for the
CT volume compared to the circumference-measured
volume, the arm volume was lower -represented by the
green dots - but matches the regression line like the
legs (represented by the blue dots).
Discussion
The safety of isolated limb perfusion and isolated limb in-







R2 Linear = 0.932
sure and limb volume measured by CT scan. There is a very high







































leg: R2 Linear = 0.758
arm: R2 Linear = 0.258
Figure 3 Correlation of body weight and limb volume by circumference measure. Green dots represent arms and blue dots represent legs.






































leg: R2 Linear = 0.610
arm: R2 Linear = 0.069
Figure 4 Correlation between BMI and limb volume by circumference measure. Green dots represent arms and blue dots represent legs.
Again, the 95% confidence intervals span a wide range.







































leg: R2 Linear = 0.093
arm: R2 Linear = 0.217
Figure 5 Correlation of IBW and limb volume by circumference measure. Green dots represent arms and blue dots represent legs. The
coefficient of determination (R2) lies below 25% for both arms and legs, indicating that the IBW is the worst predictor for the extremity volume.






























R2 Linear = 0.693
Figure 6 Correlation between circumference measured limb volume corrected with IBW/ABW-ratio and “no-fat CT volume”.
The coefficient of determination (R2) shows that approximately 70% of all values fit the model.
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during the procedure [13,30]. This is very much dependent
on the volume of the extremity [16,17]. Arms and legs have
very different limb volumes and factors such as age (espe-
cially in younger children), body weight and constitution of
the patient that will ultimately affect the limb volume and
recommended drug dosage. Thus, the exact dosage of the
drugs is dependent on a precise volumetry of the limb in
order to maintain the balance between a good response of
the tumor and a low rate of local complications.
This study had the following three major aims: i.) to val-
idate a circumference-measure volume model that was de-
veloped to allow for exact calculation of the limb volume
for drug dosage in ILP; ii.) to compare body weight- and
height-dependent measures to the limb volume model in
terms of the accuracy of the model because the use of
weight-based parameters for the dosage of drug calcula-
tion in ILP and ILI has recently become more popular
[19,20]; and iii.) to develop a calculation tool that allows
for standardized and safe volume measures and dosing of
drugs in ILP and ILI.
We have shown that limb volume estimation by the cir-
cumference measure is highly reliable when compared to
CT volume measurements. Even in obese patients, there is
no relevant deviation in the circumference-measure vol-
ume model. In general, there is a smaller than 5% differ-
ence in the volume obtained with the circumference model
and the corresponding CT-measured values. In contrast to
the gold standard, the immersion method, where the ex-
tremity is immersed into a water container and the change
of water level represents the exact limb volume as initially
described by Wieberdink [16] has some major advantages.
This method can be used for any patient, even highly
immobilized or bedridden patients as Byrne and his co-
authors have already described [18]. The method is cheap
and easy to apply; it requires no special equipment apart
from ordinary measuring tape and a personal computer
with a java-script-enabled Internet browser.
Apart from the aforementioned points, there is one fur-
ther advantage of note. If used with a waterproof marker
pen, the circumference-measure method allows for easy
dose adjustment in the femoral and brachial tourniquet
placement. Because all frustums of a cone in the model
are added successively, single volumes can be subtracted
from the total volume, according to the true tourniquet
placement in reference to the measurement markings on
the patient’s skin. Especially in the leg, the proximal parts
can easily make up half of the limb volume, which could
lead to a drastic overdose if not subtracted.
An even easier alternative to the circumference volume
measures is determining the limb volume or dose calcula-
tion by body weight- or height-dependent parameters
[18-20], which has been described for systemic chemo-
therapy [1,2]. When using the ideal body weight as aparameter, a possible advantage is the fact that a high
amount of fat tissue (especially in obese patients) will not
be excessively represented in the limb volume [20,30].
As we have shown in this study, any body weight par-
ameter by itself has a higher level of error compared to
the limb volume. Especially for the arm, the deviation
can easily reach 50% for patients with the same weight,
BMI or IBW. In addition, as already mentioned, for fem-
oral and brachial perfusions where the tourniquet can be
placed way below the axillary or the groin level (depend-
ing on the location of the tumor), the limb volume is
not actually perfused but is instead calculated by the
weight, BMI or IBW models. This could account for a
reduction in the perfused volume of up to 50%, which
would lead to a drastic overdose.
The limb volume measurement is the most reliable par-
ameter for the perfused volume compared to the CT mea-
sures, but it lacks a sufficient method of accounting for
the excess body fat in obese patients. Beasley et al. have
suggested a simple way of achieving the best of both
worlds; the limb volume calculated by the circumference
measure can be corrected by the quotient of the ideal
body weight and actual body weight [29]. For a normal
weight patient, the quotient will be close to 1, which
means that the corrected volume will be equal to the ac-
tual limb volume. On the other hand, a severely obese
(class III) patient will have a quotient of 0.5 or even less,
which will lead to a 50% reduction of the limb volume,
which is similar to what we have observed in the past by
rough estimation.
In this study, we found that the limb volume measure-
ment corrected by ideal body weight is the most appro-
priate method of limb volume estimation. This model
shows a strong correlation with the no-fat PET-CT mea-
sures, meaning that by applying this method we achieve
the best of both worlds. The individual limb volume is
measured (subtract non-perfused parts of the extremity
while taking high volume tumors into account) in com-
bination with the ability to subtract only excess fatty tis-
sue in the case of obesity.
Based on the results of this study, we have started to
adopt the IBW-corrected volume model in our clinical
practice. Further study is required to prove that this vol-
ume model leads to a reduction in the morbidity associ-
ated with compartment syndrome during ILP.
Conclusions
In summary, this study has proven that the limb volume
estimation by the circumference measure is a highly accur-
ate model of the true limb volume. The advantage of this
model lies in how easy it is to subtract the limb volume
that is not perfused from the calculation. Because the use
of body weight dependent parameters, such as the body
weight, BMI or IBW, alone is inaccurate for determining
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ume with the quotient of the ideal body weight and the
actual body weight. This model was transferred into an
html-java-script table that is available for download and
offline use [28].
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